To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06613009
Title Study of IBI3009 in Subjects With Unresectable, Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Westmead Hospital RECRUITING Westmead New South Wales 2145 Australia Details
Wollongong Hospital NOT_YET_RECRUITING Wollongong New South Wales 2500 Australia Details
Austin Hospital RECRUITING Heidelberg Victoria 3084 Australia Details
The First Affiliated Hospital of Anhui Medical University NOT_YET_RECRUITING Hefei Anhui 230022 China Details
The First Affiliated Hospital of Fujian Medical University NOT_YET_RECRUITING Fuzhou Fujian 350005 China Details
Henan Cancer Hospital NOT_YET_RECRUITING Zhengzhou Henan 450000 China Details
Hunan Cancer Hospital RECRUITING Changsha Hunan 410000 China Details
The First Affiliated Hospital of Nanchang University NOT_YET_RECRUITING Nanchang Jiangxi 330006 China Details
Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital) NOT_YET_RECRUITING Jinan Shandong 250117 China Details
Zhejiang Cancer Hospital RECRUITING Hangzhou Zhejiang 310005 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field